Research Article
Impact of Intestinal Ultrasound on Classification and Management of Crohn’s Disease Patients with Inconclusive Colonoscopy
Table 1
Demographics, Montreal classification, and laboratory markers of ultrasound and endoscopy groups.
| | | Ultrasound group | Endoscopy group | value |
| | Demographic information | | | | | Age (y) | 40.2 ± 13.8 | 37.5 ± 13.7 | .31 | | Sex (female) | 27 (66) | 43 (58) | .43 | | Previous surgery | 14 (34) | 21 (28) | .53 | | New disease | 13 (32) | 31 (41) | .32 | | Duration of disease (y) | 10.2 ± 11.9 | 7.4 ± 9.5 | .23 | | B1 (y) | 3.3 ± 5.5 | 6.7 ± 9.1 | | | B2/B3 (y) | 11.5 ± 11.4 | 8.9 ± 10.4 | | | Age at diagnosis | | | .31 | | A1 | 5 (12) | 7 (10) | | | A2 | 26 (63) | 48 (65) | | | A3 | 10 (24) | 19 (26) | | | Location of disease | | | .67 | | L1 | 23 (56) | 24 (32) | | | L2 | 5 (12) | 30 (41) | | | L3 | 12 (29) | 20 (27) | | | L4 | 1 (2) | 0 (0) | | | Disease behaviour | | | .52 | | B1 | 7 (17) | 52 (70) | | | With perianal disease | 0 | 10 | | | B2 | 20 (49) | 8 (11) | | | With perianal disease | 1 | 1 | | | B3 | 14 (34) | 14 (19) | | | With perianal disease | 0 | 2 | | | Laboratory markers | | | | | C-reactive protein (mg/L) | 27.92 ± 40.4 | 37.6 ± 59.9 | .36 | | Albumin (g/L) | 32.85 ± 5.7 | 30.7 ± 7.2 | .12 | | Hemoglobin (g/L) | 123.57 ± 20.0 | 119.95 ± 21.4 | .39 |
|
|
Continuous values are mean ± SD; discrete values are (%). Montreal classification [17]. Age of onset: A1: <17 y; A2: 17–40 y; A3: above 40 y. Location: L1: distal ileum; L2: colonic; L3: ileocolonic; L4: upper disease. Disease behaviour: B1: nonstricturing and nonpenetrating; B2: stricturing; B3: penetrating.
|
